SJ Medical
SJ Medical
Serbia has rapidly emerged as a strategic hub for medical device manufacturing and healthcare distribution in the Balkan region. With its strategic location connecting Central Europe and the Middle East, the demand for high-tech Atherectomy Systems and Vascular Interventional Devices is at an all-time high. The Serbian government's "Serbia 2025" vision emphasizes the modernization of healthcare infrastructure, specifically focusing on cardiology and peripheral vascular treatments.
Establishing or partnering with an Atherectomy System Factory in Serbia offers unique advantages, including access to a highly skilled engineering workforce from the University of Belgrade and University of Novi Sad. The local industrial zones in Kragujevac and Niš provide a fertile ground for precision medical engineering, where stringent EU-compliant standards are met with competitive operational costs.
Belgrade acts as a medical tourism and specialized treatment center for the former Yugoslavian states, driving the need for advanced plaque excision technologies.
Serbian precision mechanics and electronics sectors provide the necessary backbone for the complex assembly of orbital and rotational atherectomy devices.
Serbia's unique trade agreements allow for seamless export of medical devices to both the EU and Eurasian Economic Union markets.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems.
The prevalence of cardiovascular diseases in Serbia, often linked to dietary habits and an aging population, has necessitated the adoption of Minimally Invasive Surgery (MIS). Atherectomy systems, which physically remove plaque from blood vessels rather than just pushing it aside with a balloon, are becoming the gold standard in Serbian clinics like the Dedinje Cardiovascular Institute.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
SJ Medical strictly adheres to international quality standards. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, demonstrating its strong commitment to product quality and compliance for global markets including Serbia.
Equipped with precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure manufacturing accuracy and product consistency.
In the medical landscape of Serbia, specifically in regional centers like Niš or Kragujevac, the application of Atherectomy systems follows specific clinical pathways. Physicians are increasingly using these systems for Lower Extremity Peripheral Artery Disease (PAD) treatment, which is highly prevalent among the local population.
Our products are designed to meet these specific needs:
1. Tackling Calcification: Advanced atherectomy burrs tailored for the dense calcium deposits frequently seen in Serbian diabetic patients.
2. Compatibility: Devices are optimized to work with existing imaging infrastructure found in Serbian state and private hospitals.
3. Cost-Effectiveness: High-performance solutions that respect the budget constraints of the Serbian National Health Insurance Fund (RFZO) while maintaining European safety standards.
